Nephrologists' Reported Preparedness for End-of-life Decision-making
Overview
Affiliations
Nephrologists commonly engage in end-of-life decision-making with patients with ESRD and their families. The purpose of this study was to determine the perceived preparedness of nephrologists to make end-of-life decisions and to determine factors that are associated with the highest level of perceived preparedness. The nephrologist members of the Renal Physicians Association (RPA) and the Canadian Society of Nephrology were invited to participate in an online survey of their end-of-life decision-making practices. A total of 39% of 360 respondents perceived themselves as very well prepared to make end-of-life decisions. Age >46 yr, six or more patients withdrawn from dialysis in the preceding year, and awareness of the RPA/American Society of Nephrology (ASN) guideline on dialysis decision-making were independently associated with the highest level of self-reported preparedness. Nephrologists who reported being very well prepared were more likely to use time-limited trials of dialysis and stop dialysis of a patient with permanent and severe dementia. Compared with Americans, Canadian nephrologists reported being equally prepared to make end-of-life decisions, stopped dialysis of a higher number of patients, referred fewer to hospice, and were more likely to stop dialysis of a patient with severe dementia. Nephrologists who have been in practice longer and are knowledgeable of the RPA/ASN guideline report greater preparedness to make end-of-life decisions and report doing so more often in accordance with guideline recommendations. To improve nephrologists' comfort with end-of-life decision-making, fellowship programs should teach the recommendations in the RPA/ASN guideline and position statement.
Hatoum W, Sperling D Isr J Health Policy Res. 2024; 13(1):45.
PMID: 39256820 PMC: 11385125. DOI: 10.1186/s13584-024-00632-w.
Urgency for Kidney Palliative Care in Chinese Maintenance Hemodialysis Patients.
Zhang S, Zhu W, Xia J, Zheng Y, Li X, Chen L Kidney Int Rep. 2023; 8(12):2794-2801.
PMID: 38106567 PMC: 10719599. DOI: 10.1016/j.ekir.2023.09.006.
Time-Limited Trials for Patients With Critical Illness: A Review of the Literature.
Kruser J, Nadig N, Viglianti E, Clapp J, Secunda K, Halpern S Chest. 2023; 165(4):881-891.
PMID: 38101511 PMC: 11243441. DOI: 10.1016/j.chest.2023.12.014.
Palliative Care for Patients with Kidney Disease.
Lanini I, Samoni S, Husain-Syed F, Fabbri S, Canzani F, Messeri A J Clin Med. 2022; 11(13).
PMID: 35807208 PMC: 9267754. DOI: 10.3390/jcm11133923.
Ramspek C, Verberne W, van Buren M, Dekker F, Bos W, van Diepen M Clin Kidney J. 2021; 14(1):189-196.
PMID: 33564418 PMC: 7857791. DOI: 10.1093/ckj/sfaa021.